undamentalytics Newsletter

Desantis Carl and related entities: insider trades

10% owner at 2 companies we cover. 7 open-market purchases and 18 sales not made under a pre-set plan, reported from March 12, 2010 to November 14, 2022. Trades reported separately by several related funds or companies are counted once, under this name.

Would copying Desantis Carl and related entities’s purchases have beaten the S&P 500?

Too few purchases to judge. None of their purchases has 12 months of prices after the report; we judge insiders once they have 20. The figures below can swing a long way on a handful of trades. After their sales, the shares moved +88.8% against the index over 12 months on average (a negative figure means selling was the right call); 17% trailed it. None of their purchases could be priced, so there is no copy portfolio.

With 296 insiders tested, some will look skilled or unskilled by chance alone: when we replaced each insider’s stocks with random companies bought on the same days, about 5.7 cleared the bar ahead and 23.3 behind. One record on its own proves little.

Trade by trade

Desantis Carl and related entities: trades against the S&P 500 afterwards
MeasuredTrades countedAverage vs S&P 500MedianWent the right wayYearst-statisticp-valueEvidence
Purchases, 3 months after the report 0 — — — — — — Not enough years
Purchases, 6 months after the report 0 — — — — — — Not enough years
Purchases, 12 months after the report 0 — — — — — — Not enough years
Purchases, 12 months after the trade 0 — — — — — — Not enough years
Sales, 3 months after the report 6 +26.0% +18.9% 33% 3 — — Not enough years
Sales, 12 months after the report 6 +88.8% +61.2% 17% 3 — — Not enough years
Sales, 12 months after the trade 6 +78.1% +65.2% 17% 3 — — Not enough years

“Average vs S&P 500” is the stock’s return including dividends minus the index’s over the same dates, from the close on the first trading day after the report, or from the close on the trade date. Only windows that have finished are counted. For sales, a negative figure means the stock lagged after it was sold, so selling was the right call (green). “Went the right way” is the share of purchases that beat the index, or of sales that trailed it. The t-statistic uses one average per year of reports, because one person’s trades bunch into the same stock and weeks, and needs trades in at least four different years; the p-value comes from the t distribution with that number of years (with four years, a t of 2 has p = 0.14). “Some evidence” means p under 5%, “strong evidence” p under 1% over at least six years.

Companies traded

CompanyTitle on the latest filingPurchasesSalesFirst reportLatest report
Ibio, Inc. IBIO —412July 26, 2010September 18, 2014
Celsius Holdings, Inc. CELH —36March 12, 2010November 14, 2022

Trades and what followed

Moves are against the S&P 500; green means the trade went the insider’s way.

ReportedTradedCompanyTradeValue3 months after report12 months after report12 months after trade
November 14, 2022August 12, 2022 CELH Sale $9,575,538 −7.6%+37.8%+68.4%
August 4, 2022August 2, 2022 CELH Sale $9,981,098 0.0%+35.1%+26.6%
December 2, 2021November 24, 2021 CELH Sale $1,876,498 −15.3%+90.4%+62.1%
June 15, 2021June 14, 2021 CELH Sale $183,019,375 +37.8%−1.2%−4.7%
November 27, 2020November 24, 2020 CELH Sale $14,451,548 +73.3%+84.5%+104.0%
August 31, 2020August 25, 2020 CELH Sale $11,027,995 +67.6%+285.9%+212.3%
February 10, 2017January 31, 2017 CELH Purchase $999,999 not yetnot yetnot yet
January 18, 2017January 13, 2017 CELH Purchase $300,000 not yetnot yetnot yet
September 18, 2014September 15, 2014 IBIO Sale $93,034 not yetnot yetnot yet
February 4, 2014February 3, 2014 IBIO Sale $15,855 not yetnot yetnot yet
January 31, 2014January 30, 2014 IBIO Sale $41,276 not yetnot yetnot yet
January 29, 2014January 24, 2014 IBIO Sale $74,284 not yetnot yetnot yet
September 3, 2013August 13, 2013 IBIO Sale $18,844 not yetnot yetnot yet
September 3, 2013August 7, 2013 IBIO Sale $173,604 not yetnot yetnot yet
September 3, 2013August 5, 2013 IBIO Sale $26,759 not yetnot yetnot yet
September 3, 2013July 31, 2013 IBIO Sale $49,972 not yetnot yetnot yet
September 3, 2013July 29, 2013 IBIO Sale $17,493 not yetnot yetnot yet
September 3, 2013July 25, 2013 IBIO Sale $13,697 not yetnot yetnot yet
September 3, 2013July 23, 2013 IBIO Sale $20,127 not yetnot yetnot yet
September 3, 2013July 19, 2013 IBIO Purchase $900,993 not yetnot yetnot yet
June 1, 2011May 27, 2011 IBIO Sale $30,000 not yetnot yetnot yet
December 21, 2010January 21, 2009 IBIO Purchase $518,496 not yetnot yetnot yet
August 23, 2010August 20, 2010 IBIO Purchase $114,211 not yetnot yetnot yet
July 26, 2010July 22, 2010 IBIO Purchase $15,150 not yetnot yetnot yet
March 12, 2010March 10, 2010 CELH Purchase $64,200 not yetnot yetnot yet

Open-market purchases and sales of at least $10,000 in companies we cover, from SEC Form 4 filings; sales made under a pre-set Rule 10b5-1 plan are not shown. “Not yet” means the window has not finished or the share price was under $5 at entry. These are the shares’ moves after each trade: they say nothing about why Desantis Carl and related entities traded and do not suggest the use of non-public information. How every insider compares · the insider trading backtest.